Quantcast

WEST VIRGINIA RECORD

Thursday, March 28, 2024

Mylan Inc.

Recent News About Mylan Inc. View More

  • Mylan finalizes $465M settlement over EpiPen

    By Kyla Asbury |
    TRENTON, N.J. – Mylan Pharmaceuticals has finalized a $465 million settlement in a lawsuit that claimed it overbilled Medicaid for its emergency Epinephrine auto-injectors for at least 10 years.

  • Racketeering class action suit filed against Mylan for EpiPen prices

    By Kyla Asbury |
    CHARLESTON – A class action lawsuit has been filed against Mylan alleging the company violated consumer protection laws and the Racketeer Influenced and Corrupt Organization Act by upping the price of the epinephrine auto-injector.

  • Unnamed man sues Mylan Pharmaceuticals for ADA violations

    By Kyla Asbury |
    CLARKSBURG – An unnamed man is suing Mylan Pharmaceuticals after he claims it violated the Americans with Disabilities Act. John Doe has had a seizure disorder since approximately 1998 and became employed by Mylan on June 18, 2007, according to a complaint filed March 17 in Monongalia Circuit Court and removed to federal court on April 27.

  • Janssen says Mylan infringed on Complera patents

    By Kyla Asbury |
    CLARKSBURG - Janssen Pharmaceutica has filed a lawsuit against Mylan Pharmaceuticals, claiming patent infringement. On Sept. 23 2014, the U.S.

  • German drug maker files patent lawsuit against Mylan

    By Jessica Karmasek |
    WHEELING – A German pharmaceutical company has filed a patent infringement lawsuit against Morgantown-based Mylan Pharmaceuticals. Plaintiff Boehringer Ingelheim Pharmaceuticals Inc. contends that defendant Mylan submitted Abbreviated New Drug Applications, or ANDAs, to the Food and Drug Administration seeking the approval to make and sell generic versions of Boehringer’s Tradjenta and Jentadueto tablets. An ANDA is an application for a U.S.